Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Multicenter Study of the Pharmacokinetics, Efficacy and Safety of Olokizumab in Pediatric and Adolescent Patients With Active Juvenile Idiopathic Arthritis

NCT07517575 is registered in ClinicalTrials.gov with R-Pharm International, LLC as lead sponsor.

NCT NCT07517575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07517575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Multicenter Study of the Pharmacokinetics, Efficacy and Safety of Olokizumab in Pediatric and Adolescent Patients With Active Juvenile Idiopathic Arthritis
Lead sponsor
R-Pharm International, LLC
Phase
Phase 2
Overall status
Recruiting
Start date
March 17, 2023
Completion date
June 30, 2030
Enrollment
71 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

juvenile idiopathic arthritis